| CASE REPORT |
|
| Year : 2014 | Volume
: 18
| Issue : 6 | Page : 781-785 |
|
|
Recombinant human bone morphogenetic protein type 2 in the reconstruction of atrophic maxilla: Case report with long-term follow-up
Andre Luiz Zetola1, Thalyta Verbicaro2, Sahara Littieri3, Rafaela Larson3, Allan Fernando Giovanini2, Tatiana Miranda Deliberador3, Andre Luiz Zetola1, Thalyta Verbicaro2, Sahara Littieri3, Rafaela Larson3, Allan Fernando Giovanini2, Tatiana Miranda Deliberador3
1 Oral and Maxillofacial Surgeon, Chairman of Implantology, SOEPAR, Curitiba, PR, Brazil
2 Professor of Positivo University, Curitiba, PR, Brazil
3 Private Pratice, Curitiba, PR, Brazil
Correspondence Address:
Tatiana Miranda Deliberador
Prof. Pedro Viriato Parigot de Souza St, 5300 - CEP 81280 330 - Campo Comprido - Curitiba, PR
Brazil
Tatiana Miranda Deliberador
Prof. Pedro Viriato Parigot de Souza St, 5300 - CEP 81280 330 - Campo Comprido - Curitiba, PR
Brazil
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0972-124X.147437
|
|
|
Autologous bone is reported by scientific literature as the gold standard for the replacement of the bone loss in maxillary atrophic area. Notwithstanding, this grafting type shows several disadvantages as: The procedure morbidity, limited size of the graft and longer recovering time. Recombinant human bone morphogenetic protein type 2 (rhBMP-2) has been used as bone substitute for the reconstruction of large bone defects. The aim of this case was to report a clinical case exhibiting the reconstruction of the atrophic maxilla through using rhBMP-2 as grafting material associated with absorbable collagen sponge (ACS). At 8 months of following-up, osseointegrated implants were placed. After 2 years and 5 months of following-up, it could be observed an appropriate aesthetical and functional rehabilitation. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
| 
